Use access key #2 to skip to page content.
$32.15 1.52 (4.96%)
5/16/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar Tankota (97.63) Submitted: 5/02/08 10:24 AM : Underperform Start Price: $28.23 AMLN Score: -13.27

"We're all going to die"

Report this Post Replies: 0 | Reply

Featured Broker Partners